Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ibrahim Alghanimi
A Prospective Study Comparing Injectable Interferon Beta-1a (Rebif 22-44), (Avonex 30) and 1b (Betaseron 250) Injection Site Reaction in Multiple Sclerosis Patients
Electronic physician
Related publications
T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis
Archives of Neurology
Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a
Journal of Negative Results in BioMedicine
Genetics
Pharmacology
Molecular Biology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy
Multiple Sclerosis
Neurology
Autoimmune Hypothyroidism Associated With Interferon Beta-1b Treatment in Two Patients With Multiple Sclerosis
Australian and New Zealand Journal of Medicine
Daclizumab Is More Effective in Reducing Relapse Rates in Multiple Sclerosis Patients Than Interferon Beta-1a
Journal of pharmacology & clinical research
Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 MCG for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Increased CD80(+) B Cells in Active Multiple Sclerosis and Reversal by Interferon Beta-1b Therapy.
Journal of Clinical Investigation
Medicine
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated With Interferon Beta 1a by 1h-NMR Spectroscopy
Neurotherapeutics
Neurology
Pharmacology
